INTERNATIONAL PATENT: JUNO THERAPEUTICS, INC. FILES APPLICATION FOR "CD19-DIRECTED CHIMERIC ANTIGEN RECEPTOR CELL THERAPY FOR TREATING AUTOIMMUNE AND NEUROLOGICAL DISEASES"

GENEVA, March 11 -- JUNO THERAPEUTICS, INC. (400 Dexter Ave. N, Suite 1200Seattle, Washington 98109) filed a patent application (PCT/US2025/043808) for "CD19-DIRECTED CHIMERIC ANTIGEN RECEPTOR CELL THERAPY FOR TREATING AUTOIMMUNE AND NEUROLOGICAL DISEASES" on Aug 27, 2025. With publication no. WO/2026/050426, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KOEGEL, Ashley (c/o Bristol-Myers Squibb CompanyRoute 206 and Province Line RoadPrinceton, New Jersey 08543), CAMPBELL, Timothy (c/o Bristol-Myers Squibb CompanyRoute 2...